Results 81 to 90 of about 188,920 (206)

Coinfection of Cytomegalovirus, Pneumocystis jirovecii pneumonia, COVID-19, and Mycobacterium colombiense in an AIDS patient: A case report

Heliyon
We present an AIDS patient coinfected with Cytomegalovirus, Pneumocystis jirovecii pneumonia, nontuberculous mycobacteria, and COVID-19, who finally recovered from the coinfection. The 36-year-old man had two hospitalizations.
Zhongbao Zuo, Rongrong Zheng, Feng Li, Aifang Xu, Jinchuan Shi   +4 more
doaj   +1 more source

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series

BMC Pulmonary Medicine, 2007
Background Current systemic therapy for nontuberculous mycobacterial pulmonary infection is limited by poor clinical response rates, drug toxicities and side effects.
Jacobs Susan S, Kao Peter N, Davis Kala K, Ruoss Stephen J   +3 more
doaj   +1 more source

A case report of cutaneous infection with Mycobacterium neoaurum

Clinical Case Reports, 2023
Key Clinical Message Cutaneous infection due to Mycobacterium neoaurum in immune‐competent individuals had only been reported in limited cases. The point that makes our case very impressive was its cutaneous infection, and presentation in the immune ...
Alireza Mohebbipour‐Loren, Mehrnaz Soghrati, Sajjad Barin, Mitra Rezaei   +3 more
doaj   +1 more source

Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex

Antimicrobial Agents and Chemotherapy, 2018
Mycobacterium avium complex (MAC) and M. abscessus complex (MABC) comprise the two most important human pathogen groups causing nontuberculous mycobacterial lung disease (NTM-LD).
Sun Hye Shin, B. W. Jhun, Su-Young Kim, Junsu Choe, K. Jeon, H. Huh, C. Ki, N. Lee, Sung Jae Shin, C. Daley, W. Koh   +10 more
semanticscholar   +1 more source

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary.

Clinical Infectious Diseases, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites.
C. Daley, J. Iaccarino, C. Lange, E. Cambau, R. Wallace, C. Andrejak, E. Böttger, J. Brożek, D. Griffith, L. Guglielmetti, G. Huitt, Shandra L. Knight, P. Leitman, T. Marras, K. Olivier, M. Santin, J. Stout, E. Tortoli, J. van Ingen, D. Wagner, K. Winthrop   +20 more
semanticscholar   +1 more source

Atypical Behavior in a Typical Carcinoid: When Minimal Proliferation Meets Lympho‐Vascular Invasion—A Case Report

Thoracic Cancer, Volume 17, Issue 14, July 2026.
Left: A 46‐year‐old non‐smoking female with a 2.4 cm right hilar mass (cT1cN0M0). Middle: Postoperative pathology reveals discordance between low proliferation (Ki‐67 < 2%) and unexpected focal lympho‐vascular invasion, with concomitant granulomatous inflammation. Right: After VATS lobectomy (pN0) and active surveillance, no recurrence occurred over 20 
Qilian Wang, Xi Chen, Sicheng Zhou, Guowei Che   +3 more
wiley   +1 more source

A hidden threat: a case of relapsed disseminated Mycobacterium abscessus infection and its therapeutic challenges [PDF]

Journal of Bone and Joint Infection
Mycobacterium abscessus (M. abscessus) is a rapidly growing nontuberculous mycobacterium (NTM). We present the case of a 57-year-old female on immunosuppressive therapy for polymyalgia rheumatica (PMR) who developed disseminated M.
K. G. Egan, L. Duffy, C. Fleming, P. McGettrick, P. McGettrick, E. G. Muldoon, E. G. Muldoon, C. Kelly, C. Kelly, J. Woo, J. Woo, E. Kilbride, J. Butler, R. Storey, C. Quinlan, C. Quinlan, E. McDermott, J. Hunter, C. Mejia-Chew, C. Mejia-Chew   +19 more
doaj   +1 more source

Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus

Infection and Drug Resistance, 2018
Background The prevalence of pulmonary disease caused by nontuberculous mycobacteria (NTM) is reportedly on the rise in the world. Some of the species are resistant to various antibiotics; hence, limited treatment options are available.
A. Khosravi, M. Mirsaeidi, A. Farahani, M. Tabandeh, P. Mohajeri, S. Shoja, Seyedeh Roghayeh Hoseini Lar KhosroShahi   +6 more
semanticscholar   +1 more source

Respiratory Review of 2009: Nontuberculous Mycobacterium

Tuberculosis and Respiratory Diseases, 2009
As the prevalence of tuberculosis declines, the proportion of nontuberculous mycobacterial (NTM) lung disease is increasing in Korea. The combined use of liquid and solid media increases the sensitivity of mycobacterial culture and shortens culture time.
openaire   +1 more source

Nontuberculous Mycobacterium Arthritis and Spondylitis in a Patient with Lupus

Journal of Rheumatic Diseases, 2016
Approximately 90% of nontuberculous mycobacterium (NTM) infections involve the pulmonary system; NTM infections involving areas of the musculoskeletal system such as the joints or spine are uncommon. This report describes a case of refractory knee swelling in a patient with systemic lupus erythematosus (SLE).
Nayoung Park, Sunjoo Lee, Chisook Moon, Dongyook Kim, Heuichul Gwak, Minyoung Her   +5 more
openaire   +1 more source